Učitavanje...

Is the future of personalized therapy in triple-negative breast cancer based on molecular subtype?

Significant research has been conducted to better understand the extensive, heterogeneous molecular features of triple-negative breast cancer (TNBC). We reviewed published TNBC molecular classifications to identify major groupings that have potential for clinical trial development. With the ultimate...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Oncotarget
Glavni autori: Le Du, Fanny, Eckhardt, Bedrich L., Lim, Bora, Litton, Jennifer K., Moulder, Stacy, Meric-Bernstam, Funda, Gonzalez-Angulo, Ana M., Ueno, Naoto T.
Format: Artigo
Jezik:Inglês
Izdano: Impact Journals LLC 2015
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4536987/
https://ncbi.nlm.nih.gov/pubmed/25973541
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!